Astellas Pharma Gets Positive Opinion From European Regulator for Advanced Gastric Cancer Drug
Astellas Pharma Gets Positive Opinion From European Regulator for Advanced Gastric Cancer Drug
安斯泰萊製藥(adr)獲歐洲監管機構就先進胃癌藥物的積極意見。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊